| HOME >> MEDICINE >> TECHNOLOGY |
$
30,485,968$
30,446,427Accounts payable
$
,499,399$
,775,327Accrued expenses and other current liabilities
1,771,0591,095,732Accrued compensation
644,9912,964,812Accrued dividends
1,733,68024,570Total current liabilities
5,649,1295,860,441Deferred rent
84,91190,902Deferred grant income
76,44282,650Deferred income taxes
192,821194,244Total liabilities
6,003,3036,228,237Total stockholders' equity
24,482,66524,218,190Total liabilities and stockholders' equity
$
30,485,968$
30,446,427The Female Health CompanyUnaudited Condensed Consolidated Income StatementsThree Months Ended
December,20122011Net revenues
$
9,910,227$
8,634,442Cost of sales
3,944,0283,618,298Gross profit
5,966,1995,016,144Operating expenses
2,365,1652,232,864Operating income
3,601,0342,783,280Interest and other (expense) income
(4,244)355Foreign currency transaction loss
(37,267)(52,306)Income before income taxes
3,559,5232,731,329Income tax expense
25,67771,385Net income
$
3,533,846$
2,659,944Net income per basic common share outstanding
$ 0.12$ 0.10Basic weighted average common shares outstanding
28,333,36027,480,011Net income per diluted common share outstanding
$ 0.12$ 0.09Diluted weighted average common shares outstanding
28,694,90328,883,710Cash dividends declared per common share
$0.12$0.10
'/>"/>
| SOURCE The Female Health Company Copyright©2012 PR Newswire. All rights reserved |